Investigation of Pathogenic and Truncated Variants of RUNX1 and DDX41 in All of Us

Investigation of Pathogenic and Truncated Variants of RUNX1 and DDX41 in All of Us

Explore a comprehensive investigation into pathogenic and truncated variants of RUNX1 and DDX41 genes within the All of Us research program. Presented by Huan Mo at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting, this 11-minute conference talk delves into the significance of these genetic variations in cancer genomics. Learn about the latest findings and their potential impact on accurate cancer diagnosis and personalized treatment strategies. Gain insights into the collaborative efforts of clinical cytogeneticists, molecular geneticists, and molecular pathologists in advancing cancer genomics research and clinical practice.